GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » EBITDA Margin %

Lobe Sciences (XCNQ:LOBE) EBITDA Margin % : 0.00% (As of Feb. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Lobe Sciences's EBITDA for the three months ended in Feb. 2024 was C$-0.55 Mil. Lobe Sciences's Revenue for the three months ended in Feb. 2024 was C$0.00 Mil. Therefore, Lobe Sciences's EBITDA margin for the quarter that ended in Feb. 2024 was 0.00%.


Lobe Sciences EBITDA Margin % Historical Data

The historical data trend for Lobe Sciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences EBITDA Margin % Chart

Lobe Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -49.48 - - - -525.56

Lobe Sciences Quarterly Data
Dec18 Mar19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Aug23 Nov23 Feb24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -380.88 -

Competitive Comparison of Lobe Sciences's EBITDA Margin %

For the Biotechnology subindustry, Lobe Sciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lobe Sciences's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's EBITDA Margin % falls into.



Lobe Sciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Lobe Sciences's EBITDA Margin % for the fiscal year that ended in Aug. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Aug. 2023 )/Revenue (A: Aug. 2023 )
=-4.42/0.841
=-525.56 %

Lobe Sciences's EBITDA Margin % for the quarter that ended in Feb. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Feb. 2024 )/Revenue (Q: Feb. 2024 )
=-0.545/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lobe Sciences  (XCNQ:LOBE) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Lobe Sciences EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences (XCNQ:LOBE) Business Description

Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

Lobe Sciences (XCNQ:LOBE) Headlines

No Headlines